Showing 6531-6540 of 8783 results for "".
- New JAAD Study Offers Tips for Preventing and Detecting Skin Cancer in People of Colorhttps://practicaldermatology.com/news/20140206-new_jaad_study_offers_tips_for_preventing_and_detecting_skin_cancer_in_people_of_color/2459347/
- Valeant Pharmaceuticals to Acquire Precision Dermatology for $475 Millionhttps://practicaldermatology.com/news/20140203-valeant_pharmaceuticals_to_acquire_precision_dermatology_for_475_million/2459351/
- Acella Pharmaceuticals Announces Approval and Launch of Loutrex Topical Creamhttps://practicaldermatology.com/news/20140131-acella_pharmaceuticals_announces_approval_and_launch_of_loutrex_topical_cream/2459352/
- Study Finds Prevalence of Indoor Tanning Common in US, Europe, and Australiahttps://practicaldermatology.com/news/20140130-study_finds_prevalence_of_indoor_tanning_common_in_us_europe_and_australia/2459355/
- Valeant Pharmaceuticals Completes Acquisition of Solta Medicalhttps://practicaldermatology.com/news/20140127-valeant_pharmaceuticals_completes_acquisition_of_solta_medical/2459359/
- CeraVe Launches Two Skin Care Productshttps://practicaldermatology.com/news/20140123-cerave_launches_two_skin_care_products/2459361/CeraVe has introduced the CeraVe Eye Repair Cream and CeraVe Intensive Stretch Marks Cream. The Eye Repair Cream combines three essential ceramides, to help repair and restore the delicate barrier around the eyes, with hydrating hyaluronic acid to help diminish fine lines and wrinkles. The Intensive
- Merz Dermatology Announces Enhanced Naftin Co-Payment Savings Programhttps://practicaldermatology.com/news/20140117-merz_dermatology_announces_enhanced_naftin_co-payment_savings_program/2459370/
- Scioderm Initiates Phase IIB Study of SD-101 to Treat Epidermolysis Bullosahttps://practicaldermatology.com/news/20140107-scioderm_initiates_phase_iib_study_of_sd-101_to_treat_epidermolysis_bullosa/2459377/
- Provectus Announces Name Change to Provectus Biopharmaceuticalshttps://practicaldermatology.com/news/20131218-provectus_announces_name_change_to_provectus_biopharmaceuticals/2459391/
- Almirall S.A. to Aquire Aqua Pharmaceuticalshttps://practicaldermatology.com/news/20131217-almirall_sa_to_aquire_aqua_pharmaceuticals/2459392/